Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
Portfolio Pulse from Avi Kapoor
Jim Cramer recommends buying Modine Manufacturing and AMETEK, while expressing positive sentiments about Moderna and Mind Medicine. He advises caution on Hertz Global Holdings and notes uneven quarters for Palantir Technologies.
May 15, 2024 | 1:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jim Cramer recommends buying AMETEK, calling it an 'absolutely terrific' company despite worse-than-expected Q1 sales results.
Cramer's strong recommendation can outweigh the negative impact of the recent earnings miss.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer recommends buying Modine Manufacturing, calling it a 'terrific' industrial company. The company is set to discuss its Q4 and FY 2024 results on May 22.
Cramer's strong recommendation and upcoming financial results discussion are likely to positively impact the stock.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Jim Cramer believes in Moderna, and Evercore ISI Group initiated coverage with an In-Line rating and a $120 price target.
Positive sentiment from Jim Cramer and a new analyst rating with a price target can boost investor confidence in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Jim Cramer advises caution on Hertz Global Holdings, suggesting not to sell or double down. The company reported mixed Q1 financial results.
Cramer's cautious stance and mixed financial results suggest a neutral short-term impact.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 60
NEUTRAL IMPACT
Jim Cramer likes Mind Medicine for its potential to alleviate pain without addiction. Oppenheimer reiterated an Outperform rating but lowered the price target from $29 to $20.
While Cramer is positive, the lowered price target from Oppenheimer may neutralize the impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Jim Cramer notes that Palantir Technologies has uneven quarters. The company reported a 21% YoY increase in Q1 revenue, beating estimates.
Despite positive earnings, Cramer's comment on uneven quarters suggests a neutral short-term impact.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70